ABBV vs PODD
By Alex · Tickerpine
AbbVie Inc. vs Insulet Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | ABBV | PODD |
|---|---|---|
| Price | $295.03 | $152.48 |
| Market cap | $521.50B | $10.58B |
| P/E ratio | 50.7 | 24.9 |
| ROE | — | 28.93% |
| Profit margin | 15.67% | 13.44% |
| Revenue growth | 10.30% | 19.20% |
| Dividend yield | 2.35% | 0.00% |
| Beta | 0.19 | 1.05 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
ABBV vs PODD in plain English
- ABBV is the bigger company — about 49.3× the market cap of PODD.
- PODD is cheaper on earnings (P/E 24.9 vs 50.7).
- PODD is growing revenue faster (19% vs 10%).
- ABBV pays a dividend (2.35%) while the other effectively doesn't.
How would $1,000 have done in each?
ABBV return calculator
See what $1,000 in AbbVie Inc. would be worth today.
PODD return calculator
See what $1,000 in Insulet Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.